News and Trends 23 Feb 2018
Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a GLP-1 based treatment for type…
Intarcia
- Latest Posts
News and Trends 15 Sep 2017
Swiss-US Partners Reveal New Candidate for Autoimmune Disease
Numab and Intarcia have a first candidate to combine a tri-specific antibody fragment with a mini-osmotic pump delivery system to…
News and Trends 2 Jan 2017
Fresh Cash for a Device that Can Treat Diabetes and Prevent HIV
Intarcia will develop a drug delivery device for HIV prevention that can significantly reduce dosing frequency, backed by a €134M…
News and Trends 14 Jun 2016
Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.
Given the rates of diabetes reaching 'epidemic proportions', we figured it was time to have a better overview of biotech's…
ADVERTISEMENT
News and Trends 6 Jun 2016
Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases
Numab and Intarcia have achieved key milestones in the development of therapeutic antibody fragments. This collaboration could span the next…
News and Trends 18 Sep 2015
Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III
Treatment of diabetes hasn't changed so much since the development of first human insulin by Genentech. But Boston-based Intarcia (a…
News and Trends 31 Aug 2015
Review: The Future of Biomarkers in Immuno-Oncology
Immuno-oncology is a Biotech field that is more than just hype - it could solve one of humanity's biggest health…
News and Trends 15 Nov 2014
Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?
The French company Servier wants to invest one billion euros by a partnering with the American company Intarcia regarding their…
